The very name Nanomedicine denotes the size and the structure of the pharmacy yet it is the most promising and emerging field in pharmacology in recent times. Its prominence is on rise not because it involves and deploys innovative technology; it is getting increasingly recommended due to its precision in detecting the affected organ and reaching it with the dosages of the drug without affecting the other organs in the body. Be it chronic diseases like Tuberculosis, diabetes, epilepsy, nonomedicine come off the ages to treat the acute medical conditions like cancer and progressive cases like Alzheimer’s.

As it is still at the evolving stage, there is an acute short of teaching, learning and research centers that could promote this novice way of drug delivery. Since there are not many skilled researchers and learning and research centers engaged in the nano research, policymakers must focus in allocating appropriate funding in this direction to attract the creamy layer of the crop in this direction.

Contact details:

iMedPub LTD 483,
Green Lanes London N13 4BS, UK
contact@imedpub.com
+1-702-508-2676